clinical trial · NCT07136805
A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
VivaVision Biotech, Inc·phase3·not yet recruiting·n = 152
Non-infectious Anterior UveitisVVN461 Ophthalmic Solution 1.0%1.0% prednisolone acetate
brief summary
This is a multicenter, randomized, single-masked, active-controlled, parallel, Phase III pivotal study in China
started
Oct 1, 2025
primary completion
Dec 31, 2026
completion
Apr 30, 2027
last updated
Aug 22, 2025
official title
A Multi-center, Randomized, Single-masked, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of 1.0% VVN461 Ophthalmic Solution in Patients With Non-infectious Anterior Uveitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol